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Abstract 
The first ALS resistant Matricaria chamomilla (MATCH) biotype was found in 2006 in Schleswig Holstein in 
Witzwort (SCHLEICH-SAIDFAR et al., 2011). Since 2006 ALS resistant Matricaria chamomilla and Matricaria inodora 
(MATIN) were found at other locations near the North Sea coastline in Schleswig-Holstein and Lower Saxony 
(ULBER et al., 2012). As there were more and more cases of reduced efficacy of sulfonylureas on mayweed, Dow 
AgroSciences decided in 2012 and 2013 to test MATCH and MATIN samples in Germany. In 2012 seed samples 
collected by Dow AgroSciences were planted in greenhouse environment and treated with tribenuron or 
florasulam. As a second step plants were checked for mutations of the ALS gene at positions Pro 197 and Thr 
574 via Pyrosequencing. In Europe there is no known case of metabolic ALS-resistance (ULBER et al., 2012). It 
was found that mayweed plants showed a mutation at position Pro 197 only. In 2013 leaf samples were taken 
only and investigated for mutations of ALS position Pro 197 and Thr 574. 
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Zusammenfassung 
Die erste nachgewiesene ALS-resistente Kamille (Matricaria chamomilla/recutita) stammt aus dem Jahr 2006 
aus Witzwort in Schleswig-Holstein (SCHLEICH-SAIDFAR et al., 2011). Seit 2006 gab es einige weitere Kamille-
Standorte, bei denen eine ALS-Resistenz nachgewiesen wurde (ULBER et al., 2012). Diese befanden sich in erster 
Linie an der Nordseeküste Schleswig-Holsteins und Niedersachsens. Da sich die ALS-resistente Kamille weiter 
ausbreitete, wurden 2012 und 2013 im Auftrag von Dow AgroSciences deutschlandweit Kamille-Proben 
(MATIN und MATCH) gesammelt und untersucht. In 2012 wurden Samenproben gesammelt, die dann im 
Biotest mit Tribenuron bzw. Florasulam behandelt und danach mit Pyrosequencing an den Stellen Pro 197 und 
Thr 574 auf Mutationen untersucht wurden. Da bei ALS-Resistenz bei zweikeimblättrigen Unkräutern 
europaweit keine metabolische Resistenz bekannt ist (ULBER et al., 2012), wurden 2013 deutschlandweit 
Blattproben gesammelt und an den Stellen Pro 197 und Thr 574 auf Mutation untersucht. 
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Introduction 
The first ALS resistant Matricaria chamomilla (MATCH) biotype was found in 2006 in Schleswig 
Holstein in Witzwort (SCHLEICH-SAIDFAHR et al., 2011). During the following years ALS resistant 
MATCH and MATIN plants were found at other locations close to the coastline of the North Sea in 
Schleswig-Holstein and Lower Saxonia. There were increasing incidents of reduced efficacy of 
sulfonylurea herbicides on mayweed. A mayweed herbicide resistance monitoring program was 
carried out by the Julius-Kühn-Institut in 2011 and results were published in 2012 (ULBER et al., 
2012).  
Due to the fact that florasulam (a triazolopyrimidine herbicide from Dow AgroSciences) always 
showed full efficacy in greenhouse trials and in the field the intension was to compare the efficacy 
of triazolopyrimidines and sulfonylureas on ALS target site resistant mayweed species. 
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Material and Methods 
In 2012, 34 Matricaria seed samples were randomly collected, i.e. the Matricaria samples came 
from fields without any anticipated ALS resistance. From these collections, 19 seed samples were 
identified as Matricaria inodora and 15 seed samples as Matricaria chamomilla. The seed samples 
were investigated by EpiLogic GmbH for greenhouse efficacy testing and the ALS target site 
resistance analysis via pyrosequencing at positions Pro 197 and Thr 574. Therefore the DNA from 
the Matricaria leafs where extracted and amplified via PCR. 
 
The greenhouse trials were carried out under the following conditions: 
 5 plants per pot 
 the herbicides (40 g/ha Pointer SX or 100 ml/ha Primus) were applied at BBCH 12 
 3 repetitions per pot/variety 
 2 Matricaria standards – to compare efficacy- one ALS resistant standard and one 
susceptible standard 
 visual efficacy control after 28 days 
 14 hours day light 
 light intensity equals a cloudy day 
 temperature at night: 12 °C 
 temperature day time: 14 – 18 °C 
The target-site resistance analysis was carried out with plants from the greenhouse trials 
(untreated variety) via PCR and pyrosequencing at Pro 197 and Thr 574. Therefore the DNA from 
the Matricaria leafs where extracted and amplified via PCR. 
A mutation of the ALS gene caused reduced efficacy by an ALS inhibitor herbicide (SCHLEICH-
SAIDFAR et al., 2011). 
In 2013, 70 leaf samples of Matricaria inodora and Matricaria chamomilla were randomly collected 
in the fields. Each sample consisted of 1 leaf from each of 8 different plants. The leaves were sent 
in a paper envelope to IdentXX GmbH. ALS target site resistance analysis was conducted for each 
leaf per plant at Pro 197 and Thr 574. In total 560 different Matricaria plants (70 samples x 8 plants) 
were analyzed. 
Results 
Results 2012 – greenhouse trial and target site resistance analysis 
In 2012, investigations did not reveal any target site resistance or reduced efficacy of tribenuron 
and florasulam on Matricaria inodora. 
However, there were two samples of Matricaria chamomilla and Matricaria recutita that showed 
reduced susceptibility to tribenuron at 88% control (sample from Schleswig-Holstein) and 13% 
efficacy (sample from Nordrhein-Westfalen). In both samples target site resistance at position Pro 
179 was detected. The Schleswig-Holstein sample showed a mutation from Pro 197 to Thr 197 
with a frequency of 50% of the plants from that location, the sample from Nordrhein-Westfalen 
had a mutation from Pro 197 to Ser 197 and 71% of the plants from that location were concerned. 
There were two samples with mutations at Pro 197 but with no reduced tribenuron or florasulam 
efficacy. One sample from Sachsen-Anhalt had a frequency of 19% Pro 197 to Ser 197 and one 
sample from Brandenburg had a frequency of 17% Pro 197 to Ser 197. There was no cross 
resistance between tribenuron (sulfonylurea) and florasulam (triazolopyrimidin) (Fig. 1 and 2).  
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Fig. 1 Seed samples of Matricaria inodora. 
Abb. 1 Samenproben von Matricaria inodora. 
 
Fig. 2 Seed samples of Matricaria chamomilla. 
Abb. 2 Samenproben von Matricaria chamomilla. 
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Results 2013 – target site analysis 
ALS resistant Matricaria biotypes were found. From the 70 samples, 52 samples showed no 
mutation at position Pro 197 and Thr 574. 18 samples showed mutation at Pro 197 (Fig. 3). In 
addition, 7 out 18 samples showed a mutation to Thr 197 and 11 samples to Ser 197. 
 
Fig. 3 Results of sampling program 2013. 
Abb. 3 Ergebnisse der Probenahme 2013. 
Discussion 
The results from the 2012 and 2013 sampling program indicated occurrence of ALS resistant 
Matricaria at the North Sea coastline and further south in the region of Hannover – Bielefeld – 
Dortmund. Not all samples where ALS target site resistance was identified showed reduced 
tribenuron efficacy. Especially in eastern Germany and Bavaria Matricaria samples with mutation at 
position Pro 197 were found and they were susceptible to tribenuron. As resistance continues to 
develop in these regions there is an expectation that resistance to tribenuron will increase. The 
only mutation with Matricaria found in 2012 and 2013 was at position Pro 197 of the ALS gene. 
Cross resistance between florasulam and tribenuron in case of mutation at Pro 197 was not found 
because greenhouse trials confirmed full florasulam efficacy. Further investigations are needed to 
determine if the use of clopyralid (in Ariane C and Primus Perfect), an active ingredient belonging 
to the HRAC class O, can help to prevent development of resistant Matricaria in cereal crops. 
References 
SCHLEICH-SAIDFAR, C., H.G. DROBNY, J. PEREZ, M. FEIERLER, F.G. FELSENSTEIN, J.R. GERTZ and N. BALGHEIM, 2011: Observations, field trials 
and analysis of a special population of mayweed (Matricaria recutita) with resistance against ALS-inhibitors in Schleswig-
Holstein (Germany). J. Plant Dis. Protect. 118 (2), 87. 
ULBER, L., E. SVOBODA, B. JASER, F.G. FELSENSTEIN und P. ZWERGER 2012: Monitoring for ALS resistance in chamomille species in 
Germany. Julius-Kühn-Archiv 438, 318-319.  
